Case report: Retinal alterations in a young patient without comorbidities using injectable testosterone for aesthetic purposes

After the significant decision by the Federal Council of Medicine to veto the prescription of testosterone by doctors for aesthetic purposes, the major discussion revolves around the competence of users and other healthcare professionals regarding the monitoring of side effects that impact the patients' quality of life. This is because these individuals may potentially seek other ways to use the anabolic agent. In this case report, we present the case of a young, healthy patient without previous comorbidities, who exhibited significant ophthalmological changes during a routine check-up, consistent with systemic arterial hypertension, which had not been identified during their follow-up consultations with an endocrinologist.